iifl-logo-icon 1

Gujarat Terce Laboratories Ltd Share Price

48.37
(-4.99%)
Jul 18, 2024|03:40:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open50.91
  • Day's High50.91
  • 52 Wk High70.91
  • Prev. Close50.91
  • Day's Low48.37
  • 52 Wk Low16.65
  • Turnover (lac)4.14
  • P/E154.27
  • Face Value10
  • Book Value9.58
  • EPS0.33
  • Mkt. Cap (Cr.)35.89
  • Div. Yield0
No Records Found

Gujarat Terce Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

50.91

Prev. Close

50.91

Turnover(Lac.)

4.14

Day's High

50.91

Day's Low

48.37

52 Week's High

70.91

52 Week's Low

16.65

Book Value

9.58

Face Value

10

Mkt Cap (₹ Cr.)

35.89

P/E

154.27

EPS

0.33

Divi. Yield

0

Gujarat Terce Laboratories Ltd Corporate Action

7 Jun 2023

12:00 AM

BookCloser

arrow

7 Jun 2023

12:00 AM

AGM

Announcement Date: 07 Jun, 2023

arrow

29 Mar 2024

12:00 AM

EGM

arrow

20 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Gujarat Terce Laboratories Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Gujarat Terce Laboratories Ltd SHAREHOLDING SNAPSHOT

18 Jul, 2024|07:08 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 37.02%

Foreign: 0.00%

Indian: 37.02%

Non-Promoter- 62.97%

Institutions: 0.00%

Non-Institutions: 62.97%

Custodian: 0.00%

Share Price

Gujarat Terce Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

7.42

7.42

7.42

7.42

Preference Capital

0

0

0

0

Reserves

-0.56

1.11

0.24

3.69

Net Worth

6.86

8.53

7.66

11.11

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

40.13

25.17

37.54

29.01

yoy growth (%)

59.4

-32.93

29.39

14.73

Raw materials

-15.24

-9.99

-13.9

-10.52

As % of sales

37.99

39.68

37.03

36.25

Employee costs

-15.82

-12.96

-15.12

-11.92

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

0.74

-2.53

0.43

0.32

Depreciation

-0.27

-0.17

-0.24

-0.18

Tax paid

0.12

0.01

-0.15

-0.05

Working capital

2

-0.44

2.46

-5.43

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

59.4

-32.93

29.39

14.73

Op profit growth

-140.37

-505.13

111.34

304.73

EBIT growth

-153.58

-394.3

31.98

65.61

Net profit growth

-134.61

-1,012.54

1.98

-1,928.47

View Ratios
Particulars (Rupees in Crores.)Mar-2021Mar-2020Mar-2019

Gross Sales

25.18

37.54

31.03

Excise Duty

0

0

0

Net Sales

25.18

37.54

31.03

Other Operating Income

0

0

0

Other Income

0.8

0.29

0.32

Gujarat Terce Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,579.25

124.153,78,914.98867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,511.35

32.861,22,044.231,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,564.95

76.931,21,185.085310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,184.85

34.691,19,223.631,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,643.15

25.871,10,827.471,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Gujarat Terce Laboratories Ltd

Management

Register Office

Registrar Office

Whole-time Director

Amrutbhai P Prajapati

Independent Director

Chhayaben Ashwinbhai Shah

Independent Director

Viplav Suryakantbhai Khamar

Managing Director & CEO

Aalap Prajapati

Independent Director

Surendra Kumar Sharma

Independent Director

Navinchandra Patel

Chairman & Wholetime Director

Natwarbhai P Prajapati

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Gujarat Terce Laboratories Limited, incorporated in 1985, produces branded generic formulations for the domestic market. Over its more than three-decade business journey, the Company developed an extensive product basket comprising 50 brands covering multiple therapeutic areas which are marketed by its 180+ strong MR team across 13 Indian states. Headquartered in Ahmedabad, the Company has its fully automated facility at Chhatral, in Gandhinagar, Gujarat By 1986, Terce had established its presence in Gujarat and Rajasthan with a firm footing. In 1992, the management raised public equity to give concrete shape and listed the Company on Bombay Stock Exchange. In same year, Company established extensive manufacturing facility at Chhatral in Gandhinagar, Gujarat. As India heralded new leaps in the pharma sector to become a global force to reckon with by 2005, the Company closely followed the narrative with ferocious growth expanding presence in the domestic and international market.The Company is an ISO 9001 certified, WHO-GMP compliant operating facility manufactures world-class formulations and healthcare products that feature in acute and chronic therapeutic areas. It engaged into manufacture and sale of pharmaceutical formulations and ayurvedic medicines in India and internationally. It offers products in the form of tablets, capsules, syrups, and injections. The installed capacity of the Company is 270 million tablets and 108 million capsules per annum.The facility is ISO 90
Read More

Company FAQs

What is the Gujarat Terce Laboratories Ltd share price today?

Down Arrow

The Gujarat Terce Laboratories Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹48.37 today.

What is the Market Cap of Gujarat Terce Laboratories Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gujarat Terce Laboratories Ltd is ₹35.89 Cr. as of 18 Jul ‘24

What is the PE and PB ratio of Gujarat Terce Laboratories Ltd?

Down Arrow

The PE and PB ratios of Gujarat Terce Laboratories Ltd is 154.27 and 5.31 as of 18 Jul ‘24

What is the 52 Week High and Low of Gujarat Terce Laboratories Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Gujarat Terce Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Gujarat Terce Laboratories Ltd is ₹16.65 and ₹70.91 as of 18 Jul ‘24

What is the CAGR of Gujarat Terce Laboratories Ltd?

Down Arrow

Gujarat Terce Laboratories Ltd's CAGR for 5 Years at 51.83%, 3 Years at 78.44%, 1 Year at 101.46%, 6 Month at 53.57%, 3 Month at -16.09% and 1 Month at 6.31%.

What is the shareholding pattern of Gujarat Terce Laboratories Ltd?

Down Arrow

The shareholding pattern of Gujarat Terce Laboratories Ltd is as follows:
Promoters - 37.03 %
Institutions - 0.00 %
Public - 62.97 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.